SCHEMBL982815

SCHEMBL982815

C=CCC(c1ccccc1)S(=O)(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.58
SRC P12931 2/20 0.48
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
CYP2D6 P10635 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 3/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 2/20 0.36
OPRD1 P41143 1/20 0.35
HSD11B1 P28845 1/20 0.35
GMNN O75496 1/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
PMP22 Q01453 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27504829 0.98 CYP2C19 (0.56) CYP2C19SRCALDH1A1SMN1; SMN2CYP2D6
Ammonia Solution, Strong SCHEMBL1594791 0.98 CYP2C19 (0.56) CYP2C19SRCALDH1A1SMN1; SMN2CYP2D6
Succinic Acid SCHEMBL27674622 0.92 CYP2C19 (0.54) CYP2C19SRCALDH1A1SMN1; SMN2CYP2D6
SCHEMBL10944451 0.83 SRC (0.50) CYP2C19SRCALDH1A1SMN1; SMN2CYP2D6
SCHEMBL11825005 0.82 GABBR2 (0.42) CYP2C19CYP2D6HSD17B10LMNAKMT2A
SCHEMBL2991652 0.82 CYP2C19 (0.46) CYP2C19SRCALDH1A1CYP2D6KDM4E
SCHEMBL7580947 0.81 CYP2C19 (0.49) CYP2C19ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL28154652 0.81 SRC (0.48) CYP2C19SRCALDH1A1SMN1; SMN2CYP2D6
SCHEMBL10469067 0.81 CYP2C19 (0.45) CYP2C19SRCALDH1A1SMN1; SMN2CYP2D6
SCHEMBL13970191 0.80 CYP2C19 (0.47) CYP2C19SRCALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168192-A1 PROPPANTS DERIVED FROM CROSSLINKING MIXED AROMATIC RESINS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2023-09-07 WO claimed
US-20230279286-A1 PROPPANTS DERIVED FROM CROSSLINKING MIXED AROMATIC RESINS ExxonMobil Technology and Engineering Company (US) 2023-09-07 US claimed
WO-2021076676-A1 ETCHING COMPOSITION AND METHOD FOR EUV MASK PROTECTIVE STRUCTURE VERSUM MATERIALS US, LLC (US) 2021-04-22 WO claimed
EP-3119866-A1 LAUNDRY ARTICLE Henkel AG & Co. KGaA (DE) 2017-01-25 EP claimed
US-20150307562-A1 ENGINEERED SECRETED PROTEINS AND METHODS AXCELLA HEALTH INC. 2015-10-29 US claimed
EP-2922416-A1 ENGINEERED SECRETED PROTEINS AND METHODS Pronutria, Inc. (US) 2015-09-30 EP claimed
WO-2015139865-A1 LAUNDRY ARTICLE PUNCH INDUSTRIES (IE) 2015-09-24 WO claimed
CN-102686560-B Highly overbased magnesium alkytoluene sulfonates CHEVRON ORONITE CO 2015-06-10 CN claimed
WO-2014081884-A9 ENGINEERED SECRETED PROTEINS AND METHODS PRONUTRIA, INC. (US) 2015-05-21 WO claimed
US-20140272422-A1 ANTI-CORROSION COMPOSITIONS FOR NATURAL GAS RECOVERY OR CONVEYING EQUIPMENT JACAM CHEMICALS, LLC (US) 2014-09-18 US claimed
US-20040023817-A1 Methods of using invertible oil external-water internal fluids in subterranean applications HALLIBURTON ENERGY SERVICES, INC. 2004-02-05 US claimed
EP-1293550-A2 Drilling using invertible emulsion drilling fluids Halliburton Energy Services, Inc. (US) 2003-03-19 EP claimed
EP-0658620-B1 Structured surfactants ALBRIGHT & WILSON UK LTD (GB) 2000-08-09 EP claimed
US-5981651-A Ink processes XEROX CORPORATION (US) 1999-11-09 US claimed
US-5683847-A Toner aggregation latex processes XEROX CORPORATION (US) 1997-11-04 US claimed
US-5384060-A SOIL AND STAIN REMOVING COMPOSITION IN AN APPLICATOR STICK FORM FLUID PACKAGING COMPANY INC. (US) 1995-01-24 US claimed
US-5288421-A Solid laundry pre-spotter composition containing sodium bicarbonate and method of use FLUID PACKAGING COMPANY, INC. (US) 1994-02-22 US claimed
US-5288420-A Antisoilants comprising sodium stearate, propylene glycol, polyethylene glycol, an alkyl aromatic sulfonic acid, an alkyl aromatic sulfonate surfactant formed in situ, a bases, nonionic surfactant and an enzyme; stick forms FLUID PACKAGING COMPANY, INC. (US) 1994-02-22 US claimed
US-5215548-A Reducing deposits in internal combustion engines EXXON RESEARCH AND ENGINEERING COMPANY (US) 1993-06-01 US claimed
US-4636256-A Corrosion inhibiting system containing alkoxylated amines TEXACO INC. (US) 1987-01-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307562-A1 ENGINEERED SECRETED PROTEINS AND METHODS MRPL21, GHITM, IGFBP6 CYP2C19 4824/4885SRC 2787/4885ALDH1A1 3929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.